Literature DB >> 19802521

An unusual case of loin pain and nephritis.

Alison Lap-tak Ma1, Wai-ming Lai, Man-chun Chiu.   

Abstract

We report a 14-year-old girl with nephrotic syndrome and renal vein thrombosis (RVT) on initial presentation. The patient tested positive for antinuclear antibodies but only weakly positive for anti-double-stranded DNA (anti-dsDNA). Her C3 level was normal. Treatment with low molecular weight heparin resulted in resolution of RVT. Renal biopsy showed membranous glomerulonephritis with segmental sclerosis. Tissue immunostaining showed diffuse granular C3 and immunoglobulin (Ig)G staining along the capillary wall with focal segmental IgM staining deposits in the mesangium. No C1q, IgA, or fibrinogen was noted on immunofluorescence assay. With cyclosporin A and prednisolone, the patient went into remission and corticosteroids were tapered off gradually. Two years later, she had a relapse of proteinuria, hypocomplementemia, and extremely high anti-dsDNA. Systemic lupus erythematosus (SLE) was diagnosed, and she was promptly started on steroid and immunosuppressive agents, which resulted in reduction of proteinuria. Her renal function has been normal all along. Membranous nephropathy is uncommon in Chinese children and could be a possible early presentation of SLE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19802521     DOI: 10.1007/s10157-009-0222-2

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  22 in total

1.  The successful treatment of renal-vein thrombosis by low-molecular-weight heparin in a steroid-sensitive nephrotic patient.

Authors:  Shih-Hsien Yang; Chih-Hsiung Lee; Sheung-Fat Ko; Jin-Bor Chen; Feng-Rong Chung; Kuo-Tai Hsu
Journal:  Nephrol Dial Transplant       Date:  2002-11       Impact factor: 5.992

2.  Clinical aspects of renal vein thrombosis.

Authors:  C V HARRISON; M D MILNE; R E STEINER
Journal:  Q J Med       Date:  1956-07

3.  Clinicopathologic correlations in lupus nephritis in Lima, Peru.

Authors:  A Hurtado; C Asato; E Escudero; C S Stromquist; J Urcia; M E Hurtado; S de La Cruz; M H Wener; R Zavala; R J Johnson
Journal:  Nephron       Date:  1999       Impact factor: 2.847

Review 4.  Nephrotic syndrome with portal, splenic and renal vein thrombosis. A case report.

Authors:  Yuki Etoh; Isao Ohsawa; Takayuki Fujita; Yoshinobu Fuke; Morita Endo; Hiroyuki Ohi; Kazunari Kumasaka
Journal:  Nephron       Date:  2002       Impact factor: 2.847

Review 5.  Out-of-hospital treatment of venous thrombosis: socioeconomic aspects and patients' quality of life.

Authors:  P M Bossuyt; A G van den Belt; M H Prins
Journal:  Haemostasis       Date:  1998

6.  Systemic lupus erythematosus. Differences between patients who do, and who do not, fulfill classification criteria at the time of diagnosis.

Authors:  H Lom-Orta; D Alarcon-Segovia; E Diaz-Jouanen
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666

7.  Renal vein thrombosis and inferior vena cava thrombosis in systemic lupus erythematosus. Frequency and risk factors.

Authors:  G Mintz; E Acevedo-Vázquez; G Gutiérrez-Espinosa; F Avelar-Garnica
Journal:  Arthritis Rheum       Date:  1984-05

8.  Symptomatic thrombotic events among Egyptian patients with systemic lupus erythematosus: special consideration for renal vein thrombosis.

Authors:  A A Shahin; H Mostafa; H Sami; H A Shahin
Journal:  Z Rheumatol       Date:  2003-06       Impact factor: 1.372

9.  Significance of enzyme linked immunosorbent assay (ELISA) for antibodies to double stranded and single stranded DNA in patients with lupus nephritis: correlation with severity of renal histology.

Authors:  M Okamura; Y Kanayama; K Amastu; N Negoro; S Kohda; T Takeda; T Inoue
Journal:  Ann Rheum Dis       Date:  1993-01       Impact factor: 19.103

10.  Thrombotic complications in childhood-onset idiopathic membranous nephropathy.

Authors:  Chrystal U Louis; Bruce Z Morgenstern; Lavjay Butani
Journal:  Pediatr Nephrol       Date:  2003-10-30       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.